Clinical trial
Randomized, Blinded, Controlled Trial to EValuate the EcOnomic and ClinicaL Outcomes of Utilizing Genetic Testing to Improve Therapeutic Decision-Making COmpared to Empiric Prescribing as the StaNdard of Care
NCT02487888 is registered in ClinicalTrials.gov with Proove Bioscience, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Blinded, Controlled Trial to EValuate the EcOnomic and ClinicaL Outcomes of Utilizing Genetic Testing to Improve Therapeutic Decision-Making COmpared to Empiric Prescribing as the StaNdard of Care
- Lead sponsor
- Proove Bioscience, Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2014
- Completion date
- December 31, 2016
- Enrollment
- 100,000 (estimated)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.